# B-type Natriuretic Peptide (BNP) in Human Hypertension

> **NCT00953472** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 8 (estimated)

## Conditions studied

- Hypertension Stage 1

## Interventions

- **DRUG:** brain natriuretic peptide
- **OTHER:** no-added salt diet

## Key facts

- **NCT ID:** NCT00953472
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953472, "B-type Natriuretic Peptide (BNP) in Human Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00953472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*